About us Pricing ContactSubscribe

N

Nishan Tchekmedyian

University of California, Los AngelesORCID https://orcid.org/0000-0003-1298-0993

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro

Breast Cancer Research and Treatment2007402 citations

Nishan Tchekmedyian · Scinovex